World's Best Scientists 2026 revealed!
Terje R. Pedersen

Terje R. Pedersen

D-Index & Metrics

Medicine

D-Index
99
Citations
104115
World Ranking
8381
National Ranking
32

Overview

Terje R. Pedersen is affiliated with Oslo University Hospital in Norway. Their research primarily spans the fields of Medicine and Economics, Econometrics and Finance, with a particular focus on Surgery, Economics and Econometrics, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Immunology.

The scientist's work is concentrated on topics related to Lipoproteins and Cardiovascular Health, Health Systems and Economic Evaluations, Diabetes and Cardiovascular Risks linked to Lipoproteins, Atherosclerosis and Cardiovascular Diseases, Pharmaceutical Economics and Policy, Acute Myocardial Infarction Research, and Cardiovascular Health and Risk Factors.

Frequent coauthors contributing to their research include Marc S. Sabatine, Anthony Keech, Robert P. Giugliano, Sabina A. Murphy, and Huei Wang.

Terje R. Pedersen has published articles in several notable venues, with repeated publications in JAMA Cardiology and Circulation, and additional contributions to the Russian Journal of Cardiology, The Lancet, and Stroke.

Selected recent papers authored or coauthored by Terje R. Pedersen include:

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, 2020, Russian Journal of Cardiology
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis, 2020, Stroke
  • An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial, 2020, JAMA Cardiology
  • LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial, 2020, European Journal of Preventive Cardiology

Best Publications

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    A.G. Olsson;J McMurray;G Thorgeirsson;C Spaulding

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  • European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    J Perk;G De Backer;H Gohlke;I Graham

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    A Halliday;C Baigent;F Mach;B Mihaylova;B Mihaylova

  • 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

    Pyŏrälä K;Pedersen Tr;Kjekshus J;Faergeman O

  • High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

    Terje R. Pedersen;Ole Faergeman;John J. P. Kastelein;Anders G. Olsson

  • Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

    Anne B. Rossebø;Terje R. Pedersen;Kurt Boman;Philippe Brudi

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

    James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

    R. Agca;S. C. Heslinga;S. Rollefstad;M. Heslinga

  • 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

    Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  • Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

    Hallvard Holdaas;Bengt Fellstrom;Alan G Jardine;Ingar Holme

  • Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

    S. Matthijs Boekholdt;Benoit J. Arsenault;Samia Mora;Terje R. Pedersen

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    Terje R Pedersen

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    David Preiss;Sreenivasa Rao Kondapally;Paul Welsh;Sabina A. Murphy

Frequent Co-Authors

Ingar Holme
Ingar Holme Norwegian School of Sport Sciences
Anders G. Olsson
Anders G. Olsson Karolinska Institute
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Anthony C. Keech
Anthony C. Keech University of Sydney
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Peter S. Sever
Peter S. Sever Imperial College London
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
John Kjekshus
John Kjekshus University of Oslo
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Kristian Wachtell
Kristian Wachtell Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine, there are several online degrees and career pathways that offer flexibility and specialized skills for a rewarding healthcare career. Many students pursue foundational programs, such as an online degree in nutrition, which opens doors to roles in wellness, dietetics, and preventive care.

For working adults interested in advancing to healthcare management or administration, finding whats the best online mha program for working adults can make a big difference in career growth while balancing work and study.

Nursing professionals looking to enhance their credentials may benefit from rn to bsn programs that do not require traditional clinicals, making it easier for active RNs to complete their degrees online.

For those seeking the highest clinical roles in nursing, some of the online dnp programs offer fast and flexible pathways to a Doctor of Nursing Practice degree, preparing you for leadership, advanced practice, or academic roles.

Best Scientists Citing Terje R. Pedersen

Trending Scientists

Recently Published Articles